Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
about
Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depressionRole of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.Experimental medication treatment approaches for depression.Long-term effects of the treatment of depressive female inpatients in a naturalistic study: is early improvement a valid predictor of outcome?Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depressionExercise as an add-on strategy for the treatment of major depressive disorder: a systematic review.A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and PromisesOmega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo ResponseAtypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.Is depression simply a nonspecific response to brain injury?Accelerated Intermittent Theta Burst Stimulation for Suicide Risk in Therapy-Resistant Depressed Patients: A Randomized, Sham-Controlled Trial.Mechanisms of antidepressant resistanceAdjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials.A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.Placebo response in binge eating disorder: a pooled analysis of 10 clinical trials from one research group.Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation.What if a placebo effect explained all the activity of depression treatments?Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder.Placebo Response as a Latent Characteristic: Application to Analysis of Sequential Parallel Comparison Design Studies
P2860
Q24193570-8C807982-C2D5-4DD6-A8C7-2C8404D53839Q33578486-840693DB-86EC-47B4-B437-79E17A0D2812Q33635577-C2B0E6AC-E7C4-4809-9368-C1B7900CD9F5Q33908224-79BAB6C8-8092-426F-AED1-1A2441C0D0EDQ33956313-0CD73709-9A57-4475-8D00-45FC66441D43Q34407932-8401C3BC-D245-443B-B6D2-F2991B5988D7Q34476432-1BF72433-CCAB-4877-9C16-A515845990A9Q35901561-B698E2AE-578E-40ED-B967-E43A317185E5Q36059902-8502C2C3-6423-4F48-A9BF-82F1414F4DC8Q36588685-61B21F43-FCFF-4857-BD08-A4698B2C446BQ36832408-64516ECA-DB93-4F9F-8DE9-5D59A1F66908Q37202687-9E6C0A07-8C6A-4E96-982C-754F063D99AEQ37284703-42323686-F193-42D1-B590-02B79E9ECD17Q37334088-22829DF4-B069-4E07-BDFA-20EDB567DB64Q37644483-4D0B22EC-188D-4747-B8D8-B84592162859Q37665039-80A53339-03AF-4719-BD04-4671093FE076Q37713743-A5BF6FA1-DF37-4BC6-ADC5-B2BFE5CEB271Q38254452-6DD1D66D-F912-4A38-B363-EE006AD24845Q38543238-005E0B57-56D9-4F9C-82A5-9E124EC9B93AQ38792671-55237008-51D6-429A-9255-0D6CACA2AF4DQ38850169-64934596-840A-4A2B-A5A9-55F852B80B17Q39277728-66A19350-F725-4191-8A3E-825DD8B0415AQ39878590-C3459444-50D6-4A3D-BD34-6E304260754AQ41411517-54C6850C-D7EE-40AA-A57F-E10A9F7D446AQ42018058-4B69C6F3-CD6B-4197-9A00-BEF49C1AA275Q47657288-72444FAF-5B0D-4FBE-8ECC-4FD56834350FQ57654436-DF2DEBCC-8EBA-40F0-8501-7985539E01B2
P2860
Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Correlation between different ...... ive disorder: a meta-analysis.
@ast
Correlation between different ...... ive disorder: a meta-analysis.
@en
Correlation between different ...... ive disorder: a meta-analysis.
@nl
type
label
Correlation between different ...... ive disorder: a meta-analysis.
@ast
Correlation between different ...... ive disorder: a meta-analysis.
@en
Correlation between different ...... ive disorder: a meta-analysis.
@nl
prefLabel
Correlation between different ...... ive disorder: a meta-analysis.
@ast
Correlation between different ...... ive disorder: a meta-analysis.
@en
Correlation between different ...... ive disorder: a meta-analysis.
@nl
P356
P1476
Correlation between different ...... ive disorder: a meta-analysis.
@en
P2093
George I Papakostas
Nadia Iovieno
P304
P356
10.4088/JCP.11R07485
P577
2012-10-01T00:00:00Z